Found 465 matching trials
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia PHASE2 The purpose of this study is to compare the efficacy and safety of venetocl...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Venetoclax and Decitabine in R/R T-ALL PHASE2 The goal of this phase 2 clinical trial is to test the efficacy of decitabi...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
PRO#0118: Decitabine Plus Mini Flu-Bu PHASE1 This is a single institution study of combining decitabine with fludarabine...
Show More Location
Hackensack University Medical Center - John Theurer Cancer Center
Learn More & Join Trial
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies PHASE1 This trial will look at a drug called SEA-CD70 with and without azacitidine...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy PHASE2 The goal of this clinical trial is to learn if participants treated with th...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson
Learn More & Join Trial
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia PHASE1 Background:
Acute myeloid leukemia (AML) is a cancer of the white blood ce...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction PHASE3 To compare efficacy and safety between SGI-110 and Treatment Choice in adul...
Show More Location
Mayo Clinic Cancer Center
Learn More & Join Trial
Oral Arsenic Trioxide for NPM1-mutated AML PHASE2 A prospective open-label phase 2 study will be designed to assess the effic...
Show More Location
The University of Hong Kong
Learn More & Join Trial
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old PHASE1 A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Show More Location
Hospital Universitario Príncipe de Asturias
Learn More & Join Trial
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia PHASE2 The researchers are doing this study to find out whether a 3-drug combinati...
Show More Location
Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial